ABSTRACT
INTRODUCTION
Morinda citrifolia L. (Rubiaceae) -popularly known in Hawaii and Brazil as noni, is also called "indian mulberry", "ba ji tian", "nono", "nonu", "cheese fruit", and "nhau". It is one of the most traditional and popular medicinal plants in Polynesia, and its use has been recorded for over 2000 years (Earle 2001) . Noni is native to Southeastern Asia (Indonesia) and Australia, this small evergreen tree or shrub is noted for its extremely wide range of environmental tolerances and now has a pantropical distribution, found even at Central and South America (from Mexico to Panama, Venezuela and Surinam) (Nelson 2006) . All parts of the plant, especially the fruit, have been utilized as a food source or for its medicinal properties (Cardon 2003 , Wang et al. 2002 . As a medicinal plant, noni has been used to prevent and cure several diseases. Its therapeutic effects include antimicrobial, analgesic, hypotensive, anti-infl ammatory, anticancer and 585-594 586 LEONARDO P. FRANCHI et al. immunological system stimulation effects (ChanBlanco et al. 2006 , Wang et al. 2002 , Yu et al. 2008 . Currently, the use of Morinda citrifolia has become widespread, and its products are commercially available in health food stores, chain grocery stores specializing in natural foods, and on the internet. Both leaves and fruits are processed and sold as capsules, tea, and juice forms, although the fruit juice is the predominant formulation.
The anti-infl ammatory, analgesic, hypotensive and cardiovascular activities of Morinda citrifolia were reviewed in Chan-Blanco et al. (2006) . Antimicrobial effects of ethanol and hexane extracts of noni have been described, including their antitubercular activity, with the extracts inhibiting the growth of Mycobacterium tuberculosis by 89-95% (Saludes et al. 2002) . Immunomodulatory effects were demonstrated for commercially available juice (Tahitian Noni ® Juice -TNJ); polysaccharide-rich substance from noni juice (noni-ppt) and fruit juice concentrates, both in vivo and in vitro (Hirazumi and Furusawa 1999 , Hirazumi et al. 1996 , Palu et al. 2008 , and recently Harada et al. (2009) detected neuroprotective effect of noni juice against the development of ischemic neuronal damage in mice. Furthermore, noni-ppt showed antitumor activity in the Lewis lung peritoneal carcinomatosis model (Hirazumi and Furusawa 1999) and prophylactic and therapeutic potential against the immunomodulatorsensitive sarcoma 180 tumor system (Furusawa et al. 2003) . The anticarcinogenic properties of the TNJ have been observed at the initiation stage of chemical carcinogenesis, by preventing the carcinogen-DNA adduct formation and/or by acting as an antioxidant (Wang and Su 2001) .
Over 150 phytochemical compounds have already been identifi ed in the noni plant (for a review see Chan-Blanco et al. 2006) , and the major micronutrients are phenolic compounds, organic acids and alkaloids. The fruit is described to have fl avonoids, lignans and coumarins (Potterat and Hamburger 2007) . Although antraquinones occur nearly exclusively in the roots (Deng et al. 2007, Ohsawa and Ohba 1993) , a potent quinone reductase (QR) inducer, 2-methoxy-1,3,6-trihydroxyanthraquinone, has been reported to be present in the fruit, which could account for the cancer chemopreventive activity exerted by noni (Pawlus et al. 2005 ).
Noni has been tested in various bioassays, in vitro and in vivo, to indicate the absence and/ or evaluate its genotoxic potential, including gene mutation (HPRT), unscheduled DNA synthesis (UDS), Comet assay, Ames test (Westendorf et al. 2007) , micronucleus in mouse, chromosomal aberration in human lymphocytes (Edwards 2002 (Edwards , 2003 and somatic mutation and homologous recombination in Drosophila melanogaster (Franchi et al. 2008) .
The purpose of this study was to directly evaluate antimutagenic and/or antirecombinagenic effects of TNJ using the Somatic Mutation and Recombination Test (SMART). This assay is based on the loss of heterozigosity (LOH) induction that may occur through various mechanisms, such as point and chromosomal mutations, as well as mitotic recombination. This versatile short-term in vivo assay detects simultaneously mutational and mitotic recombination, being able to quantify the recombinagenic activity of a compound in a genotoxicity screening (Franchi et al. 2009 , Téllez et al. 2007 , Toledo et al. 2008 .
MATERIALS AND METHODS

CHEMICAL COMPOUNDS
In this study we used a commercial noni fruit juice produced by 
TREATMENTS
Eggs derived from ST crossing were collected for 8 h on standard medium enriched with baker's yeast supplemented with sucrose. After 72 ± 4 h, third-instar larvae were collected by fl otation in running water and placed in bottles containing 0.9 g of Drosophila instant medium (Carolina Biological Supply Company, Burlington, NC, USA) rehydrated with 3 mL of the treatment solutions. The co-treatment was carried out by mixing the mutagens, MMC (0.05 mM) or DXR (0.2 mM), with three concentrations of TNJ (25%, 50%, and 75% v/v). Larvae were fed on instant medium until pupation (about 48 h). After emergence, adult fl ies were collected from the treatment vials and stored in 70% ethanol. Their wings were mounted in Faure's solution on slides and wing hair mutations were analyzed under a 400× magnifi cation.
SCORING OF WINGS
The induction of LOH in the marker-heterozygous fl ies produce two mutant clones types: (i) single spots, either mwh or fl r 3 , resulting from point or chromosome mutations as well as mitotic recombination, and (ii) twin spots, consisting of both mwh and fl r 3 subclones, originating exclusively from mitotic recombination (Graf et al. 1984 ). In the balancer-heterozygous genotype, mwh spots refl ect predominantly somatic point mutation and chromosome mutation, since mitotic recombination involving the balancer chromosome and its structurally normal homologue is a lethal event (Vogel et al. 1999 ).
DATA COLLECTION AND STATISTICAL ANALYSIS
Two complete independent experimental procedures were performed. As the data of each individual experiment were not heterogeneous (p experiment were not heterogeneous (p experiment were not heterogeneous ( clearly < 0.05 in the Kruskall-Wallis Test), all data were pooled for statistical testing. The adults from each experimental group were collected and both fl ies' wings were mounted on slides. Both dorsal and ventral sides of the wings were analyzed; altogether approximately 48,800 cells were examined per fl y. The relative frequencies of each type of mutant clone per fl y in a treatment series were compared pair-wise (i.e., genotoxin versus genotoxin + TNJ) using the conditional binomial test according to Kastenbaum and Bowman (1970) . The data was evaluated according to the multiple decision procedure proposed by Frei and Würgler (1988, 1995) resulting in four possible diagnostic: positive, negative, inconclusive or weak positive antigenotoxicity.
RESULTS
Prior to the antigenotoxicity assessment, TNJ was submitted to a dose range test, demonstrating that concentrations from 25 to 100% v/v do not exert toxic effects (Franchi et al. 2008) . The concentrations used to assess TNJ antigenotoxic effects ranged from 25 to 75% v/v and were coadministered with 0.05 mM of MMC or 0.2 mM of DXR. These concentrations induce genotoxic effects without affecting fl y survival, as also observed in previously published results (Rezende et al. 2011 , Santos 1999 .
The antigenotoxic effects of TNJ, measured by the wing SMART, after chronic co-exposure to MMC and DXR are summarized in Table I The effect on mutation and recombination induced by both genotoxins, and its modulation by TNJ is shown in Figure 1 . MMC (0.05 mM) induced a total of 24.17 spots per fl y through a combination of mutation and recombination, while 25, 50 and 75% concentrations of TNJ decreased this frequency to 14.60, 8.25 and 4.40, respectively. MMC alone induced 5.31 spots per fl y due exclusively to mutation, and 18.86 due to mitotic recombination. TNJ administered in the culture media reduced the MMC mutational frequency to 2.27, 1.86 and 0.60, while the MMCrecombinational frequency was decreased to 12.33, 6.39 and 3.80 respectively, demonstrating a doseresponse effect for both MMC-genotoxic events. DXR (0.2 mM) induced a total frequency of 10.37 spots, but when TNJ (25, 50 and 75%) were co-administered this frequency dropped to 3.80, 2.43 and 1.35 (Table I) . DXR induced 0.85 spots per fl y due exclusively to mutation and all TNJ concentrations reduced DXR mutation to a similar value of ~0.30 spots (Figure 1 ). We observed a clear dose response behavior to DXR recombinational frequency that changed from 9.49 to 3.41, 2.10 and 1.05, in TNJ concentrations of 25, 50 and 75%, respectively. In terms of TNJ antigenotoxic potential these frequencies represent a drop of 56-66% and 63-87% in the frequency of mutation and recombination induced by DXR. 
Twin spots m=5
Total spots m=2
TABLE I Effect of the co-treatment (TNJ + MMC and TNJ + DXR) in somatic cells of
Drosophila melanogaster using the wing SMART standard cross. Drosophila melanogaster using the wing SMART standard cross. Considering these fi ndings, we decided to evaluate the antimutagenic and/or antirecombinagenic action of TNJ. In our study, the cotreatment with different concentrations of TNJ plus DXR or MMC induced a statistically signifi cant dose-response reduction in the frequencies of spots in fl ies.
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DXR and MMC are two well known antineoplasic agents used in the treatment of solid tumors (Begleiter 2000 , Minotti et al. 2004 ). DXR inhibits the activity of the enzyme topoisomerase II, inducing DNA strand breaks (Islaih et al. 2005 , Resende et al. 2006 , while MMC acts primarily by promoting DNA crosslinkage (Efi mov and Fedyunin 2010 , Riley and Workman 1992 , Tomasz et al. 1987 . Through these mechanisms, MMC and DXR are able to induce mutations and chromosomal aberrations in both tumor and nontumor cells. Moreover, cellular enzymes are capable of converting DXR and MMC into free radical metabolites (Benchekroun et al. 1993 , Dusre et al. 1989 , Menegola et al. 2001 ), which in turn induce damage to several molecules, such as DNA.
Many studies have suggested the coadministration of antineoplasic agents and free radical scavengers, such as antioxidants, to reduce the genotoxicity of such treatments in non-tumor et al. 1998 et al. , Tavares et al. 2006 . So, the noni juice may be promising in this scenario. In this study, TNJ produced a marked decrease in all kinds of MMC-and DXR-induced mutant spots. However, the largest effect observed in the co-administration of TNJ with MMC and DXR was antirecombinagenic, resulting in 82 and 87% reductions, respectively.
The mechanisms by which TNJ exerts its antigenotoxic activity are not clear at the present. However, antioxidant and/or free radical scavenger activities could be suggested. The radical scavenging activity has been measured in vitro using the terazolium nitroblue (TNB) assay, by assessing the juice's potential capacity to protect cells or lipids from oxidative alteration promoted by a superoxide anion radical (SAR). The SAR scavenging activity of TNJ was 2.8 times higher than that of vitamin C, and 1.4 times higher than that of pycnogenol and grape seed powder (Wang and Su 2001). TNJ's protective effects were proportional to the concentrations applied, indicating a dose-response correlation.
Iridoids and potent antioxidant phenolic compounds, such as deacetylasperulosidic acid, scopoletin, isoscopoletin, aesculetin, 7-hydroxycoumarin (7-HC), quercetin, americanin A have been identifi ed in noni fruits (Dussossoy et al. 2011 , Ikeda et al. 2009 , Liu et al. 2007 , Su et al. 2005 , West et al. 2011 . These fi ndings suggest that several compounds, in particular iridois and phenolic compounds, could contribute separately or synergistically to an antioxidative and antigenotoxic activity in TNJ.
Alternatively, the antigenotoxic activity detected for TNJ could be attributed to the presence of QR inducers. These compounds, such as 2-methoxy-1,3,6-trihydroxyanthraquinone (Pawlus et al. 2005) , scopoletin and quercetin (Nitteranon et al. 2011) , have been described in noni fruit. QR is a phase II metabolizing enzyme that is induced in conjunction with other protective phase II enzymes. This induction of phase II enzymes, such as QR, is considered as a cancer chemopreventive -since potential oxidative and electrophilic molecules can be more readily metabolized and excreted before its interaction with cellular macromolecules, such as DNA. QR is also responsible for maintaining the reduced states of antioxidants such as α-tocopherol 592 LEONARDO P. FRANCHI et al. and coenzyme Q10. QR inducers are sometimes referred to as "indirect antioxidants", and this activity is considered protective at the initiation stage of carcinogenesis (Dinkova-Kostova and Talalay 2000, Kensler 1997) . This study has successfully used the SMART to demonstrate the protective effects of TNJ on the genotoxicity of DXR and MMC. We conclude that TNJ provides greater protection against these drugs, and that antirecombinagenic activity was the predominant effect. A dose-response relationship was also observed and might be attributed mainly to their powerful scavenger ability. Nevertheless, further experiments should be carried out to gain a better understanding of the mechanism of action of noni phytocompounds and to ensure their safe clinical use. 
